Real-World Insurance Claims Analysis of Venous Thromboembolism in Japanese Patients with Inflammatory Bowel Disease

被引:3
作者
Fujiya, Mikihiro [1 ]
Kawaguchi, Tsutomu [2 ]
Arai, Shoko [2 ]
Isogawa, Naoki [3 ]
Hiro, Shintaro [3 ]
Matsumoto, Fumihiro [2 ]
Yamaguchi, Satoshi [2 ,4 ]
Yoshii, Noritoshi [2 ]
Nakamura, Mashio [5 ]
Matsuoka, Katsuyoshi [6 ]
机构
[1] Asahikawa Med Univ, Dept Med, Div Gastroenterol & Hematol Oncol, 2-1 Midorigaoka Higashi, Asahikawa, Hokkaido 0788510, Japan
[2] Pfizer Japan Inc, Immunol & Inflammat Med Affairs, Shinjuku Culture Quint Bldg 3-22-7 Yoy Shibuya Ku, Tokyo 1518589, Japan
[3] Pfizer R&D Japan, Biometr & Data Management, Shinjuku Culture Quint Bldg 3-22-7 Yoy Shibuya Ku, Tokyo 1518589, Japan
[4] Int Univ Hlth & Welf, Tokyo, Japan
[5] Hidamarinooka Nakamura Med Clin, Dept Internal Med Pediat & Cardiol, 7-1510 Hidamarinooka, Kuwana 5110867, Japan
[6] Toho Univ, Dept Internal Med, Div Gastroenterol & Hepatol, Sakura Med Ctr, Sakura, Chiba 2850841, Japan
关键词
Incidence; Inflammatory bowel diseases; Japan; Risk factors; Venous thromboembolism; RISK-FACTORS; PREVENTION; PREVALENCE; THROMBOSIS; EVENTS;
D O I
10.1007/s10620-022-07388-w
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Inflammatory bowel disease (IBD), which encompasses both ulcerative colitis (UC) and Crohn's disease (CD), is a risk factor for venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE). Aim To investigate the incidence of, and risk factors for, VTE in patients with IBD in Japan. Methods This was a retrospective, non-interventional study in patients with IBD from the Japan Medical Data Center claims database. Incidence rates (IRs; unique patients with events per 100 patient-years) were calculated for VTE, DVT, and PE among the IBD, UC, and CD cohorts. Odds ratios of potential risk factors were calculated by univariate and multivariate analyses in a nested case-control design. Results Overall, 16 273 patients with IBD were included: 13 585 with UC and 3443 with CD. VTE events occurred in 1.3%, 1.2%, and 1.9% of patients with IBD, UC, and CD, respectively. In patients with IBD, UC, and CD, IRs of VTE were 0.45, 0.40, and 0.64, respectively, IRs of DVT were 0.42, 0.38, and 0.61, respectively, and IRs of PE were 0.07, 0.07, and 0.11, respectively. In patients with IBD, treatment history (immunomodulators), cardiovascular risk (hypertension, high-density lipoprotein or diabetes mellitus, and history of coronary artery disease or heart failure), malignancy, and undergoing major surgery were identified as potential risk factors for VTE in the multivariate analysis, with similar risk factors reported for patients with UC and CD. Conclusions This large study provides insight into the incidence and risk factors for VTE in patients with IBD from Japan.
引用
收藏
页码:5195 / 5205
页数:11
相关论文
共 27 条
[1]   Cardiovascular risk factors and venous thromboembolism - A meta-analysis [J].
Ageno, Walter ;
Becattini, Cecilia ;
Brighton, Timothy ;
Selby, Rita ;
Kamphuisen, Pieter W. .
CIRCULATION, 2008, 117 (01) :93-102
[2]   Prevalence and risk factors for venous thromboembolic complications in the Swiss Inflammatory Bowel Disease Cohort [J].
Alatri, Adriano ;
Schoepfer, Alain ;
Fournier, Nicolas ;
Engelberger, Rolf Peter ;
Safroneeva, Ekaterina ;
Vavricka, Stephan ;
Biedermann, Luc ;
Calanca, Luca ;
Mazzolai, Lucia .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2016, 51 (10) :1200-1205
[3]   Etiopathogenesis, Prevention, and Treatment of Thromboembolism in Inflammatory Bowel Disease [J].
Alkim, Huseyin ;
Koksal, Ali Riza ;
Boga, Salih ;
Sen, Ilker ;
Alkim, Canan .
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2017, 23 (06) :501-510
[4]   The incidence and risk factors of venous thromboembolism in Japanese inpatients with inflammatory bowel disease: a retrospective cohort study [J].
Ando, Katsuyoshi ;
Fujiya, Mikihiro ;
Nomura, Yoshiki ;
Inaba, Yuhei ;
Sugiyama, Yuuya ;
Iwama, Takuya ;
Ijiri, Masami ;
Takahashi, Keitaro ;
Tanaka, Kazuyuki ;
Sakatani, Aki ;
Ueno, Nobuhiro ;
Kashima, Shin ;
Moriichi, Kentaro ;
Mizukami, Yusuke ;
Okumura, Toshikatsu .
INTESTINAL RESEARCH, 2018, 16 (03) :416-425
[5]   Prevalence of ulcerative colitis and Crohn's disease in Japan [J].
Asakura, Keiko ;
Nishiwaki, Yuji ;
Inoue, Nagamu ;
Hibi, Toshifumi ;
Watanabe, Mamoru ;
Takebayashi, Toru .
JOURNAL OF GASTROENTEROLOGY, 2009, 44 (07) :659-665
[6]  
Bernstein CN, 2001, THROMB HAEMOSTASIS, V85, P430
[7]   High-density lipoprotein and the risk of recurrent venous thromboembolism [J].
Eichinger, Sabine ;
Pecheniuk, Natalie M. ;
Hron, Gregor ;
Deguchi, Hiroshi ;
Schemper, Michael ;
Kyrle, Paul A. ;
Griffin, John H. .
CIRCULATION, 2007, 115 (12) :1609-1614
[8]   Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study [J].
Grainge, Matthew J. ;
West, Joe ;
Card, Timothy R. .
LANCET, 2010, 375 (9715) :657-663
[9]   The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease [J].
Harbord, Marcus ;
Annese, Vito ;
Vavricka, Stephan R. ;
Allez, Matthieu ;
Barreiro-de Acosta, Manuel ;
Boberg, Kirsten Muri ;
Burisch, Johan ;
De Vos, Martine ;
De Vries, Anne-Marie ;
Dick, Andrew D. ;
Juillerat, Pascal ;
Karlsen, Tom H. ;
Koutroubakis, Ioannis ;
Lakatos, Peter L. ;
Orchard, Tim ;
Papay, Pavol ;
Raine, Tim ;
Reinshagen, Max ;
Thaci, Diamant ;
Tilg, Herbert ;
Carbonnel, Franck .
JOURNAL OF CROHNS & COLITIS, 2016, 10 (03) :239-254
[10]   Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study [J].
Kappelman, Michael D. ;
Horvath-Puho, Erzsebet ;
Sandler, Robert S. ;
Rubin, David T. ;
Ullman, Thomas A. ;
Pedersen, Lars ;
Baron, John A. ;
Sorensen, Henrik T. .
GUT, 2011, 60 (07) :937-943